Posted by Michael Wonder on 21 Jul 2020
White House weighs resurrecting key drug price initiatives
20 July 2020 - It's a sharp reversal from just a year ago, when the White House abandoned the policy over worries it would hike seniors' Medicare premiums.
The White House is weighing the revival of a major drug pricing proposal that would effectively eliminate rebates from government drug plans, six people with knowledge of the discussions told POLITICO.
The renewed focus on the so-called rebate rule comes as White House aides prepare a package of executive orders on drug pricing aimed at showing progress on one of President Donald Trump's signature campaign promises.
